EP Patent

EP0287036A2 — New pharmaceutical compositions comprising esters or amides as active ingredients

Assigned to Ono Pharmaceutical Co Ltd · Expires 1988-10-19 · 38y expired

What this patent protects

The present invention relates to new pharmaceutical compositions characterizing that esters or amides are suspended or dissolved in a middle chain glyceride or a mixture thereof. These pharmaceutical compositions inhibit the degradation of the active ingredient (i.e. esters or am…

USPTO Abstract

The present invention relates to new pharmaceutical compositions characterizing that esters or amides are suspended or dissolved in a middle chain glyceride or a mixture thereof. These pharmaceutical compositions inhibit the degradation of the active ingredient (i.e. esters or amides) by the action of various digestive enzymes in digestive system.

Drugs covered by this patent

Patent Metadata

Patent number
EP0287036A2
Jurisdiction
EP
Classification
Expires
1988-10-19
Drug substance claim
No
Drug product claim
No
Assignee
Ono Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.